期刊
BULLETIN OF THE HISTORY OF MEDICINE
卷 83, 期 2, 页码 331-377出版社
JOHNS HOPKINS UNIV PRESS
DOI: 10.1353/bhm.0.0218
关键词
postgraduate medical education; continuing medical education; pharmaceutical promotion; pharmaceutical industry; prescribing behavior; Kefauver hearings; American Medical Association
Recent critiques of the role of pharmaceutical promotion in medical practice invoke a nostalgic version of 1950s and 1960s medicine as representing all uncomplicated relationship between in innovative pharmaceutical industry and all idealistic and sovereign medical profession-a relationship that was later corrupted by regulatory or business practice changes in the 1980s or 1990s. However, the escalation of innovation and promotion in the pharmaceutical industry at mid-century had already provoked a broader crisis of overflow in medical education ill which physicians came to rise both commercial and professional sources ill air attempt. to keep modern by incorporating emerging therapeutics into their practices. This phenomenon was simultaneously a crisis for the medical profession-playing a key role in attempts to inculcate a rational therapeutics-and a marketing opportunity for the pharmaceutical industry, and produced the structural Foundations for contemporary debates regarding the role of pharmaceutical promotion in medical practice. Tracing the issue front tire advent of the wonder drugs through today's concerns regarding formal CME, we document how and why the pharmaceutical industry was allowed (and even encouraged) to develop and maintain the central role it. now plays Within postgraduate medical educational and prescribing practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据